淋巴结清扫及采样在临床N0期NSCLC手术中的意义

尚立群, 王伟, 宋伟安, 文锋, 李军, 李辉

尚立群, 王伟, 宋伟安, 文锋, 李军, 李辉. 淋巴结清扫及采样在临床N0期NSCLC手术中的意义[J]. 中国肿瘤临床, 2006, 33(12): 702-705.
引用本文: 尚立群, 王伟, 宋伟安, 文锋, 李军, 李辉. 淋巴结清扫及采样在临床N0期NSCLC手术中的意义[J]. 中国肿瘤临床, 2006, 33(12): 702-705.
Shang Liqun, Wang Wei, Song Weian, Wen Feng, Li Jun, Li Hui. The Significance of Systematic Mediastinal Lymphadenectomy and Mediastinal Lymph node Sampling in Operations of Stage-N0 NSCLC[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(12): 702-705.
Citation: Shang Liqun, Wang Wei, Song Weian, Wen Feng, Li Jun, Li Hui. The Significance of Systematic Mediastinal Lymphadenectomy and Mediastinal Lymph node Sampling in Operations of Stage-N0 NSCLC[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2006, 33(12): 702-705.

淋巴结清扫及采样在临床N0期NSCLC手术中的意义

详细信息
    通讯作者:

    尚立群 shang_liqun@126.com

  • 中图分类号: R734.2

The Significance of Systematic Mediastinal Lymphadenectomy and Mediastinal Lymph node Sampling in Operations of Stage-N0 NSCLC

  • 摘要: 目的 :研究临床分期为N0的NSCLC术后淋巴结转移情况与术后生存率之间的差异,探讨临床分期为N0的NSCLC纵隔淋巴结清扫或采样的必要性。 方法 :回顾1985年1月~2000年6月手术切除的术前判断为N0的手术病例,对比术后淋巴结转移情况,判断术前cTNM与pTNM的偏差,以及患者生存率的变化。 结果 :本组cTNM分期总的准确率为42.32%(201/475),临床Ⅰ期的NSCLC(cT1N0M0、cT2N0M0)中出现N1或N2淋巴结转移的病例(pT1N1M0、pT1N2M0、pT2N1M0、pT2N2M0)与未出现转移的病例(pT1N0M0、pT2N0M0)之间的生存率之间差异显著,P<0.01。本组cT3N0M0与pT3N1M0、pT3N2M0之间生存率差异不明显。 结论 :尽管临床Ⅰ期的NSCLC(cT1N0M0、cT2N0M0)临床上无淋巴结转移证据,但由于临床分期与术后病理分期客观上存在差异,淋巴结清扫及采样仍是必要的,任何不能行淋巴结清扫的肿瘤局部治疗方法都可能是不充分的。
    Abstract: Objective :To evaluate pre-and postoperative mediastinal metastasis and survival rateand to discuss the necessity of systematic mediastinal lymphadenectomy and mediastinal lymph nodesampling during surgery of stage-N0 non-small cell lung cancer (NSCLC). Methods :Comparative studyof postoperative mediastinal metastasis and survival rate of N0 NSCLC between those without metastasis(N0) and with metastasis (N1 or N0) was conducted to evaluate the necessity of systematic mediastinallymphadenectomy and mediastinal lymph node sampling during surgery of N0 NSCLC. Results :The to-tal accuracy of cTNM staging was 42.32 (201/475), and the difference was more significant in thosewithout metastasid:\PDF\.pdfs (pT1N0M0,pT2N0M0) than those with metastasis (pT1N1M0,pT1N2M0,pT2N1M0,pT2N2M0) in the stage-ⅠNSCLC (cT1N0M0,cT2N0M0) (P<0.01), but the difference was not significantbetween cT3N0M0 and pT3N1M0, pT3N2M0. Conclusions :Though no evidence of mediastinal lymphnode metastasis has been found in the stage-Ⅰ NSCLC (cT1N0M0,cT2N0M0), the systematic mediastinallymphadenectomy and mediastinal lymph node sampling in clinical N0 NSCLC operations are still nec-essary owing to the difference between the clinical stage and postoperative pathologic stage. Any localtherapy without systematic mediastinal lymphadenectomy and mediastinal lymph node sampling is in-complete and unsatisfactory in the treatment of stage-N0 NSCLC.
  • [1] Leschber G,Holinka G,Linder A.Video-assisted medi-astinoscopic lymphadenectomy (VAMLA)-a method for system-atic mediastinal lymphnode dissection[J].Eur J Cardiothorac Surg,2003,24(2):192-195
    [2] Kuzdal J,Zielinski M,Papla B,et al.Transcervical extended me-diastinal lymphadenectomy-the new operative technique and ear-ly results in lung cancer staging[J].Eur J Cardiothorac Surg,2005,27(3):384-390
    [3] 李玉,李厚文,胡永校,等.肺癌纵隔淋巴结转移及广泛廓清的价值[J].中华肿瘤杂志,1997,19(4):303-306
    [4] Keller SM,Adak S,Wagner H,et al.Mediastinal lymph node dis-section improves survival in patents with stages Ⅱ and Ⅲa smallcell lung cancer[J].Ann Thorac Surg,2000,70:358-366
    [5] 吴一龙,王思愚,黄植番,等.Ⅰ-ⅢA 期非小细胞肺癌淋巴结清扫范围的前瞻性研究[J].中华肿瘤杂志,2001,23(1):43-45
    [6] Izbicki JR,Passlick B,Pantel K,et al.Effectiveness of radical sys-tematic mediastinal lymphadenectomy in patients with respectablenon- small cell lung cancer:results of a prospective randomizedtrial[J]. Ann Surg,1998,227(1):138-144
    [7] Passlick B,Kubuschock B,Sienel W,et al.Mediastinal lym-phadenectomy in non-small cell lung cancer:effectiveness in pa-tients with or without nodal micrometastases-results of a pre-liminary study[J].Eur J Cardiothorac Surg,2002,21(3):520-526
    [8] 王思愚,吴一龙.系统性纵隔淋巴结清扫术在肺癌外科治疗中的重要性[J].中国肺癌杂志,2001,4(4):263-267
    [9] Le Chevalier T,Scagliotti G,Natale R,et al.Efficacy of gemc-itabine plus platinum chemotherapy compared with other plat-inum containing regimens in advanced non-small-cell lung can-cer:a meta-analysis of survival outcomes[J].Lung Cancer,2005,47(1):69-80
    [10] Rube C,Fleckenstein J.Combined-modality treatment of non-small-cell lung cancer stages I- III (take home messages) [J].2004,45(Suppl 2):S139-S141
计量
  • 文章访问数:  3
  • HTML全文浏览量:  0
  • PDF下载量:  1
  • 被引次数: 0
出版历程
  • 收稿日期:  2006-02-18
  • 修回日期:  2006-05-07
  • 发布日期:  2006-06-29

目录

    /

    返回文章
    返回